Preeclampsia & Eclampsia

Definition

  1. Hypertension in pregnancy: (CPG HTN pg82)
    1. SBP ≥140 mmHg and/or DBP ≥90 mmHg
  2. Significant proteinuria: (CPG HTN pg82)
    2. 24hr urine protein: ≥300 mg/24hr
    3. Spot UPCR: ≥30 mg/mmol
    4. Dipstick: 2+ (approx. ≥300 mg/day)
    5. (Training Manual pg16) IMG_1740.jpeg
  3. Edema: (Training Manual pg16)
    1. Endothelial damage resulting in accumulation of fluid evidenced by pitting oedema following 12 hours of recumbant bedrest.
    2. Weight gain ≥1 kg/week + proteinuria = increasing severity of PIH
    3. Edema is common in pregnancy & may not be usual sign for early detection of PIH

Classification

Classification of HTN in Pregnancy (by Training Manual)

1. Pregnancy Induced Hypertension (PIH)

Definition: Hypertension after the 20th week of pregnancy in a previously normotensive woman. It may be associated with proteinuria. The condition is expected to return to normal after pueperium.

  • Gestational Hypertension (GH)—PIH without proteinuria
  • Pre-eclampsia (PE)—PIH with proteinuria
  • Eclampsia—PIH with convulsions
  • HELLP syndrome is a severe form of PE manifested by Haemolysis, Elevated Liver Enzymes and Low Platelets.

2. Chronic Hypertension in Pregnancy

Definition: Presence of hypertension of at least 140/90 mmHg before 20 weeks of pregnancy OR beyond 6 weeks postpartum.
i. Essential HTN
ii. Secondary HTN

3. Chronic Hypertension with Superimposed PE

Definition: PE in women who have pre-existing hypertension.

  • Criteria used should include worsening hypertension, proteinuria and non-dependent oedema.

Classification of HTN in Pregnancy (by ISSHP)

1. Preeclampsia

  • Followed by normalisation of the BP by three months postpartum.
  • Oedema is no longer part of the definition of PE.
  • Excessive weight gain or failure to gain weight in pregnancy may indicate the onset of PE.
1. De novo PE (new HTN)

Definition: diagnosed after 20w with one or more of the following:

  1. Significant proteinuria
  2. Renal insufficiency: serum creatinine ≥90 micromol/l or oliguria
  3. Liver disease: raised transaminases and/or severe right upper quadrant or epigastric pain
  4. Neurological problems: convulsions (eclampsia), hyperreflexia with clonus or severe headaches, persistent visual disturbances (scotoma)
  5. Haematological disturbances: thrombocytopenia, coagulopathy, haemolysis
  6. Fetal growth restriction
2. Chronic HTN with Superimposed PE

Definition: diagnosed in woman with chronic HTN with the presence any of the following:

  1. De novo proteinuria after 20 weeks gestation
  2. A sudden increase in the severity of hypertension
  3. Appearance of features of PE-eclampsia
  4. Worsening proteinuria in a woman with pre-existing proteinuria early in gestation
3. Gestational HTN

Definition: Hypertension detected for the first time after 20 weeks gestation.

  • Progress to PE in 25% of cases
4. Isolated office hypertension

Definition: elevated BP of 140/90 mmHg only in the clinic with normal BP demonstrated by ambulatory BP monitoring (ABPM) either awake or during sleep.

  • Progress to GH in 50% cases or PE in 8% cases
5. Chronic HTN

Definition: HTN diagnosed before 20 weeks gestation or presence of HTN preconception, or de novo hypertension in late gestation that fails to resolve three months postpartum.

IMG_1742.jpeg

Preeclampsia

Definition

  • potentially life-threatening HTN disorder in pregnancy
  • characterized by vascular dysfunction and systemic inflammation involving brain, kidney, liver of mother
  • Definition & Criteria

Pathogenesis

Training Manual

  1. Impaired trophoblastic invasion or maternal spiral arteries
  2. Poor trophoblastic perfusion
  3. Endothelial injury
  4. Altered endothelial permeability
  5. Utero-placental ischemia
  6. Results in activation of coagulation

Blueprints

Abnormal development of placental vasculature and maternal systemic endothelial dysfunction.

  1. Placental under perfusion -> growth restriction & hypoxia
  2. Endothelial dysfunction (primarily by circulating antiangiogenic factors) -> increase vascular permeability, activation of coagulation cascade, microangiopathic hemolysis, vasoconstriction -> clinically hypertensive & proteinuric

Gabbe

1. Uterine vascular changes

  • Migratory interstitial & endovascular trophoblasts -> modify spiral arterioles -> develop uteroplacental arteries -> low resistance, low pressure, high flow system
  • Stage 1: first trimester, conversion of decidual segments of spiral arterioles by endovascular trophoblast migration
  • Stage 2: second trimester,conversion of myometrial segments by second wave of trophoblasts
  • Extensive fibrinoid formation & degeneration of muscular layer in arterial wall
  • Modification of of spiral arterioles into distended, tortuous, funnel-shaped vessels
  • Abnormal in PE: inhibition of second wave of endovascular trophoblast migration, usually occur in >18w gestation
  • vascular changes only found in the decidual segments of uteroplacental artery
  • the myometrial segments of spiral arterioles continue to exhibit their musculoelastic architecture

2. Vascular endothelial activation & inflammation

  • Placental factors i.e. soluble fms-like tyrosine kinase 1 (sFlt-1) bind to VEGF (vascular endothelial growth factor) & PLGF (placental-like growth factor) -> reduced levels of free VEGF & PLGF -> endothelial dysfunction
  • PLGF is angiogenic growth factors
  • The angiogenic imbalance results in manifestations of endothelial cell permeability and increased platelet aggregation
    IMG_1749.jpeg

Risk Factors

Risk for PIH (Training Manual)

  1. Maternal age <20y/o and >35y/o
  2. Primigravida
  3. History of PIH
  4. Multiple gestation
  5. Polyhydramnios
  6. Non-immune fetal hydrops
  7. Underlying renal disease
  8. Chronic HTN
  9. DM
  10. Gestational trophoblastic disease (molar pregnancy)
  11. Low socio-economic group
  12. Pregnancies with different partners
  13. Excessive weight gain
  14. Rh incompatibility

Risk for PE (Blueprints)

IMG_1741.jpeg

Risk for PE (Gabbe’s)

IMG_1748.jpeg

Clinical Risk Factor for PE (ISSHP)

IMG_1743.jpeg

Complications

Blueprints

1. Maternal

IMG_1745.jpeg

2. Fetal

IMG_1746.jpeg

Training Manual

IMG_1747.jpeg

Clinical Presentation

Blueprint

1. Gestational hypertension

2. Preeclampsia without severe features

3. Preeclampsia with severe features

4. HELLP Syndrome

5. Acute Fatty Liver of Pregnancy

Gabbe’s

IMG_1750.jpeg
IMG_1751.jpeg